COVID-19 Update: Learn how New York Proton Center is taking all the necessary precautions to keep you safe.
Dr. Isabelle Choi is the Director of Research, Clinical Director, and a Research Associate Professor at the New York Proton Center. She is appointed to national and international leadership positions in both the proton therapy and conventional photon therapy communities. Dr. Choi is a Radiation Oncology Attending in the Department of Radiation Oncology at Memorial Sloan Kettering Cancer Center.
Prior to joining the New York Proton Center, Dr. Choi was the Clinical Director at the California Protons Cancer Therapy Center in San Diego, California, where she also served as the Associate Director of Clinical Research and the Chief of the Breast Cancer, Thoracic Oncology, and Gynecologic Services for the center. She was then appointed Assistant Professor at the University of Maryland School of Medicine and served as a clinical lead of the Maryland Proton Treatment Center.
→ Gastrointestinal (GI) cancers
→ Ductal carcinoma in situ (DCIS)
Harvard University
University of Texas Health Science Center School of Medicine
Kaiser Permanente Los Angeles Medical Center (Chief Resident)
Radiation Oncology
Dr. Choi’s research focuses on improving outcomes, reducing toxicities and more effectively delivering radiotherapy for breast cancer and gastrointestinal malignancies. As NYPC’s Director of Research, she oversees 22 clinical trials across numerous types of cancers. She is the principal investigator of numerous clinical trials at NYPC, including:
– Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early-Stage Breast Cancer
– A Randomized Phase III Trial Evaluating the Role Of Axillary Lymph Node Dissection In Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
– Phase III Randomized Trial of Proton Beam Therapy (PBT) Versus Intensity Modulated Photon Radiotherapy (IMRT) for the Treatment of Esophageal Cancer
– Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors.
Among her select national leadership appointments, Dr. Choi is Chair of the Proton Collaborative Group (PCG) Publications Committee, Chair of the PCG Breast Subcommittee, Chair of the National Association of Proton Therapy’s Physician Advisory Committee, and President of the Korean American Society of Radiation Oncology.
